Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN EPIDERMOID CARCINOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 36 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barry, OP; Kazanietz, MG
      Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    2. Bernard, B; Fest, T; Pretet, JL; Mougin, C
      Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle

      CELL DEATH AND DIFFERENTIATION
    3. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
      Histone acetylation and the cell-cycle in cancer

      FRONTIERS IN BIOSCIENCE
    4. Shah, MA; Schwartz, GK
      Cell cycle-mediated drug resistance: An emerging concept in cancer therapy

      CLINICAL CANCER RESEARCH
    5. Redkar, AA; Meadows, GG; Daoud, SS
      UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    6. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Akiyama, T; Akinaga, S; Kitajima, M
      UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery

      JAPANESE JOURNAL OF CANCER RESEARCH
    7. Sausville, EA; Arbuck, SG; Messmann, R; Headlee, D; Bauer, KS; Lush, RM; Murgo, A; Figg, WD; Lahusen, T; Jaken, S; Jing, XX; Roberge, M; Fuse, E; Kuwabara, T; Senderowicz, AM
      Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

      JOURNAL OF CLINICAL ONCOLOGY
    8. Shanmugasundaram, N; Ravichandran, P; Reddy, PN; Ramamurty, N; Pal, S; Rao, KP
      Collagen-chitosan polymeric scaffolds for the in vitro culture of human epidermoid carcinoma cells

      BIOMATERIALS
    9. Kaubisch, A; Schwartz, GK
      Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development

      CANCER JOURNAL
    10. Shah, MA; Schwartz, GK
      The relevance of drug sequence in combination chemotherapy

      DRUG RESISTANCE UPDATES
    11. Mani, S; Wang, CG; Wu, KM; Francis, R; Pestell, R
      Cyclin-dependent kinase inhibitors: novel anticancer agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Chen, BB; Bronson, RT; Klaman, LD; Hampton, TG; Wang, JF; Green, PJ; Magnuson, T; Douglas, PS; Morgan, JP; Neel, BG
      Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis

      NATURE GENETICS
    13. Jones, CB; Clements, MK; Redkar, A; Daoud, SS
      UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    14. Iseki, K; Nakao, K; Nakata, K; Shima, Y; Hamasaki, K; Kato, Y; Ishii, N; Eguchi, K
      Diverse regulations of albumin gene expression by hepatocyte growth factorin HepG2 human hepatoma cells and primary culture of rat hepatocytes

      INTERNATIONAL JOURNAL OF ONCOLOGY
    15. Stroop, CJM; Weber, W; Gerwig, GJ; Nimtz, M; Kamerling, JP; Vliegenthart, JFG
      Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor

      GLYCOBIOLOGY
    16. Senderowicz, AM
      Small molecule modulators of cyclin-dependent kinases for cancer therapy

      ONCOGENE
    17. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Kitajima, M
      UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA

      JAPANESE JOURNAL OF CANCER RESEARCH
    18. Fuse, E; Hashimoto, A; Sato, N; Tanii, H; Kuwabara, T; Kobayashi, S; Sugiyama, Y
      Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01from human alpha(1)- acid glycoprotein

      PHARMACEUTICAL RESEARCH
    19. Akinaga, S; Sugiyama, K; Akiyama, T
      UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a newgeneration of anti-cancer agents for the new century?

      ANTI-CANCER DRUG DESIGN
    20. Hollosy, F; Meszaros, G; Bokonyi, G; Idei, M; Seprodi, A; Szende, B; Keri, G
      Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells

      ANTICANCER RESEARCH
    21. Kurata, N; Imabeppu, S; Nitoh, M; Kobayashi, H; Kuwabara, T; Kobayashi, S
      The effect of different dosing schedules of UCN-01 on its pharmacokineticsand cardiohaemodynamics in dogs

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    22. Usuda, J; Saijo, N; Fukuoka, K; Fukumoto, H; Kuh, HJ; Nakamura, T; Koh, Y; Suzuki, T; Koizumi, F; Tamura, T; Kato, H; Nishio, K
      Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells

      INTERNATIONAL JOURNAL OF CANCER
    23. Tang, L; Boise, LH; Dent, P; Grant, S
      Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing Bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01)

      BIOCHEMICAL PHARMACOLOGY
    24. Senderowicz, AM; Sausville, EA
      Preclinical and clinical development of cyclin-dependent kinase modulators

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    25. Mack, PC; Gandara, DR; Bowen, C; Edelman, MJ; Paglieroni, T; Schnier, JB; Gelmann, EP; Gumerlock, PH
      RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma

      CLINICAL CANCER RESEARCH
    26. Akiyama, T; Shimizu, M; Okabe, W; Tamaoki, T; Akinaga, S
      Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycleprogression and CDC2 cyclin B-1 regulation in A431 cells synchronized at Mphase by nocodazole

      ANTI-CANCER DRUGS
    27. Akiyama, T; Sugiyama, K; Shimizu, M; Tamaoki, T; Akinaga, S
      G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation

      JAPANESE JOURNAL OF CANCER RESEARCH
    28. Kurata, N; Kuwabara, T; Tanii, H; Fuse, E; Akiyama, T; Akinaga, S; Kobayashi, H; Yamaguchi, K; Kobayashi, S
      Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor,UCN-01

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    29. Sugiyama, K; Akiyama, T; Shimizu, M; Tamaoki, T; Courage, C; Gescher, A; Akinaga, S
      Decrease in susceptibility toward induction of apoptosis and alteration inG(1) checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine)

      CANCER RESEARCH
    30. GRAZIANO RF; GOLDSTEIN J; SUNDARAPANDIYAN K; SOMASUNDARAM C; KELER T; DEO YM
      TARGETING TUMOR-CELL DESTRUCTION WITH CD64-DIRECTED BISPECIFIC FUSIONPROTEINS

      Cancer immunology and immunotherapy
    31. CHEN BK; LIU YW; YAMAMOTO S; CHANG WC
      OVEREXPRESSION OF HA-RAS ENHANCES THE TRANSCRIPTION OF HUMAN ARACHIDONATE 12-LIPOXYGENASE PROMOTER IN A431 CELLS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    32. LIU YW; CHEN BK; CHEN CJ; ARAKAWA T; YOSHIMOTO T; YAMAMOTO S; CHANG WC
      EPIDERMAL GROWTH-FACTOR ENHANCES TRANSCRIPTION OF HUMAN ARACHIDONATE 12-LIPOXYGENASE IN A431 CELLS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    33. FRITZER M; SZEKERES T; SZUTS V; JARAYAM HN; GOLDENBERG H
      CYTOTOXIC EFFECTS OF A DOXORUBICIN-TRANSFERRIN CONJUGATE IN MULTIDRUG-RESISTANT KB CELLS

      Biochemical pharmacology
    34. GANESAN S; MASILAMANI V
      PHOTODYNAMIC ACTIVITY ON HUMAN LARYNX EPIDERMOID CARCINOMA CELL-LINE,HE(P)-2

      Medical oncology
    35. GANESAN S; MASILAMANI V
      PHOTODYNAMIC ACTIVITY ON HUMAN LARYNX EPIDERMOID CARCINOMA CELL-LINE,HE(P)-2

      Medical science research
    36. MODJTAHEDI H; STYLES J; DEAN C
      THE GROWTH-RESPONSE OF HUMAN TUMOR-CELL LINES EXPRESSING THE EGF RECEPTOR TO TREATMENT WITH EGF AND OR MABS THAT BLOCK LIGAND-BINDING

      International journal of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 15:45:31